Hackensack, NJ - According to Tom Bergeron of NJBiz, "Hackensack University Medical Center was once again named the top hospital in New Jersey by the prestigious U.S. News & World Report Best Hospitals rankings, which were released Tuesday morning. Hackensack was nationally ranked in five of the identified specialties and rated “high performing” in six others, helping it earn the No. 4 overall honor in the New York City area."
Hackensack, NJ – According to New Jersey Business Magazine, “Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center in Washington, and John Theurer Cancer Center, part of Hackensack University Medical Center in Hackensack, have announced that they have developed a joint cancer research agenda as part of a multi-year plan to form a National Cancer Institute (NCI) recognized cancer consortium. This recognition would support the scientific excellence of the two centers along with their capability to integrate multi-disciplinary, collaborative research approaches to focus on all the aspects of cancer.
South Orange, NJ - According to New Jersey Business magazine, "Hackensack University Health Network (HackensackUHN) and Seton Hall University (SHU) sign a definitive agreement to form a new, four-year school of medicine. Earlier this year, HackensackUHN and SHU signed a memorandum of understanding regarding the establishment of the school."
Hackensack, NJ - Hackensack University Medical Center announces that Yukiko Kimura, M.D., chief of Pediatric Rheumatology at the Joseph M. Sanzari Children’s Hospital, and her team have been awarded $2.8 million in funding by the Patient-Centered Outcomes Research Institute (PCORI) to study treatment strategies for juvenile idiopathic arthritis (JIA). The study is one of just 46 proposals that PCORI approved for funding to advance the field of comparative clinical effectiveness research (CER) and provide patients, healthcare providers, and other clinical decision makers with information that will help them make better-informed choices.
Do not miss a single innovative moment and sign up for our newsletter!